Close Menu

influenza

Biosearch said it is the first to license the CDC influenza signatures, and that it will manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

The company will use $2.2 million to develop a PCR-based multiple flu test.

Duke’s Genome center will use the money to develop diagnostic tools for upper respiratory disease.

The $600,000 award also strengthens Inviragen's ties to UW-Madison. The company's CSO maintains an academic appointment and a research lab within the School of Veterinary Medicine, which has collaborated with Inviragen on other projects.

Rapid influenza diagnostic tests only detect the new H1N1 strain and other flu viruses between 40 and 69 percent of the time, according to a pilot study by CDC researchers.

The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.

The firm has been cleared by FDA to include data from two studies that shows its Respiratory Viral Panel can be an effective aid in detecting the virus.

IP Update: Apr 30, 2009

Premium

USPTO Publishes One Patent, Seven Patent Applications Related to RNAi

The CDC's assay will run on ABI's 7500 Fast Dx Real-Time PCR instrument or the research use only 7500 Real-Time PCR instrument.

The study, begun last year, will take longer than the June 2009 timeframe projected late last year. It calls for the NIH to analyze the ability of the Biosafety Level 4 lab to contain 13 toxins to be studied there, and ensure it can run safely.

Pages

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.